172 related articles for article (PubMed ID: 37353592)
21. HLAIb worldwide genetic diversity: New HLA-H alleles and haplotype structure description.
Paganini J; Abi-Rached L; Gouret P; Pontarotti P; Chiaroni J; Di Cristofaro J
Mol Immunol; 2019 Aug; 112():40-50. PubMed ID: 31078115
[TBL] [Abstract][Full Text] [Related]
22. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study.
Sala N; Muñoz X; Travier N; Agudo A; Duell EJ; Moreno V; Overvad K; Tjonneland A; Boutron-Ruault MC; Clavel-Chapelon F; Canzian F; Kaaks R; Boeing H; Meidtner K; Trichopoulos A; Tsiotas K; Zylis D; Vineis P; Panico S; Palli D; Krogh V; Tumino R; Lund E; Bueno-de-Mesquita HB; Numans ME; Peeters PH; Quirós JR; Sánchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Hallmans G; Stenling R; Manjer J; Allen NE; Travis RC; Khaw KT; Jenab M; Offerhaus GJ; Riboli E; González CA
Int J Cancer; 2012 May; 130(10):2417-27. PubMed ID: 21681742
[TBL] [Abstract][Full Text] [Related]
23. Prostate Stem Cell Antigen Gene Polymorphism Is Associated with
Tahara T; Tahara S; Horiguchi N; Kato T; Shinkai Y; Okubo M; Terada T; Yoshida D; Funasaka K; Nagasaka M; Nakagawa Y; Kurahashi H; Shibata T; Tsukamoto T; Ohmiya N
Cancer Prev Res (Phila); 2019 Sep; 12(9):579-584. PubMed ID: 31213476
[TBL] [Abstract][Full Text] [Related]
24. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.
García-González MA; Bujanda L; Quintero E; Santolaria S; Benito R; Strunk M; Sopeña F; Thomson C; Pérez-Aisa A; Nicolás-Pérez D; Hijona E; Carrera-Lasfuentes P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellise M; Zaballa M; González-Huix F; Espinós J; Titó L; Barranco L; Pazo-Cid R; Lanas A
Int J Cancer; 2015 Sep; 137(6):1362-73. PubMed ID: 25721731
[TBL] [Abstract][Full Text] [Related]
25. PKLR- GBA region shows almost complete linkage disequilibrium over 70 kb in a set of worldwide populations.
Mateu E; Pérez-Lezaun A; Martínez-Arias R; Andrés A; Vallés M; Bertranpetit J; Calafell F
Hum Genet; 2002 Jun; 110(6):532-44. PubMed ID: 12107439
[TBL] [Abstract][Full Text] [Related]
26. PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population.
Wang S; Wu S; Zhu H; Ding B; Cai Y; Ni J; Wu Q; Meng Q; Zhang X; Zhang C; Li X; Wang M; Chen R; Jin H; Zhang Z
Sci Rep; 2016 Mar; 6():23465. PubMed ID: 27001215
[TBL] [Abstract][Full Text] [Related]
27. Impact of
Yan K; Wu K; Lin C; Jie Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31416884
[TBL] [Abstract][Full Text] [Related]
28. An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations.
Kayser M; Krawczak M; Excoffier L; Dieltjes P; Corach D; Pascali V; Gehrig C; Bernini LF; Jespersen J; Bakker E; Roewer L; de Knijff P
Am J Hum Genet; 2001 Apr; 68(4):990-1018. PubMed ID: 11254455
[TBL] [Abstract][Full Text] [Related]
29. rs2294008T, a risk allele for gastric and gallbladder cancers, suppresses the PSCA promoter by recruiting the transcription factor YY1.
Saeki N; Ono H; Yanagihara K; Aoyagi K; Sasaki H; Sakamoto H; Yoshida T
Genes Cells; 2015 May; 20(5):382-91. PubMed ID: 25727947
[TBL] [Abstract][Full Text] [Related]
30. Lactase haplotype diversity in the Old World.
Hollox EJ; Poulter M; Zvarik M; Ferak V; Krause A; Jenkins T; Saha N; Kozlov AI; Swallow DM
Am J Hum Genet; 2001 Jan; 68(1):160-172. PubMed ID: 11095994
[TBL] [Abstract][Full Text] [Related]
31. The
Wang XF; Liu DL; Geng L
Genet Test Mol Biomarkers; 2023 Feb; 27(2):44-55. PubMed ID: 36853840
[No Abstract] [Full Text] [Related]
32. HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes.
Alter I; Gragert L; Fingerson S; Maiers M; Louzoun Y
PLoS Comput Biol; 2017 Aug; 13(8):e1005693. PubMed ID: 28846675
[TBL] [Abstract][Full Text] [Related]
33. A haplotype method detects diverse scenarios of local adaptation from genomic sequence variation.
Lange JD; Pool JE
Mol Ecol; 2016 Jul; 25(13):3081-100. PubMed ID: 27135633
[TBL] [Abstract][Full Text] [Related]
34. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
Oleksyk TK; Nelson GW; An P; Kopp JB; Winkler CA
PLoS One; 2010 Jul; 5(7):e11474. PubMed ID: 20634883
[TBL] [Abstract][Full Text] [Related]
35. PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected].
Kupcinskas J; Wex T; Link A; Bartuseviciute R; Dedelaite M; Kevalaite G; Leja M; Skieceviciene J; Kiudelis G; Jonaitis L; Kupcinskas L; Malfertheiner P
Anticancer Res; 2014 Dec; 34(12):7167-75. PubMed ID: 25503145
[TBL] [Abstract][Full Text] [Related]
36. Association of MUC1 5640G>A and PSCA 5057C>T polymorphisms with the risk of gastric cancer in Northern Iran.
Alikhani R; Taravati A; Hashemi-Soteh MB
BMC Med Genet; 2020 Jul; 21(1):148. PubMed ID: 32660489
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants at 8q24 are associated with risk of esophageal squamous cell carcinoma in a Chinese population.
Dai N; Zheng M; Wang C; Ji Y; Du J; Zhu C; He Y; Zhu M; Zhu X; Sun M; Dai J; Ma H; Chen J; Hu Z; Gu H; Jin G; Shen H
Cancer Sci; 2014 Jun; 105(6):731-5. PubMed ID: 24654646
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms PSCA rs2294008, IL-4 rs2243250 and MUC1 rs4072037 are associated with gastric cancer in a high risk population.
Gonzalez-Hormazabal P; Retamales-Ortega R; Musleh M; Bustamante M; Stambuk J; Pisano R; Valladares H; Lanzarini E; Chiong H; Suazo J; Quiñones LA; Varela NM; Castro VG; Jara L; Verdugo RA; Berger Z
Mol Biol Rep; 2020 Nov; 47(11):9239-9243. PubMed ID: 33128686
[TBL] [Abstract][Full Text] [Related]
39. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
[TBL] [Abstract][Full Text] [Related]
40. Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.
Kohaar I; Porter-Gill P; Lenz P; Fu YP; Mumy A; Tang W; Apolo AB; Rothman N; Baris D; Schned AR; Ylaya K; Schwenn M; Johnson A; Jones M; Kida M; Silverman DT; Hewitt SM; Moore LE; Prokunina-Olsson L
J Natl Cancer Inst; 2013 Jan; 105(1):69-73. PubMed ID: 23266392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
